Zidesamtinib targets ROS1+ NSCLC patients with prior TKI treatment, addressing CNS-penetrant treatment challenges and ...

Neladalkib showed a 31% ORR in TKI-pretreated ALK+ NSCLC patients, with durable responses at 12 and 18 months.

INSYTE marks the first FDA-approved clinical trial of an intravascular optical imaging system designed specifically for the neurovasculature. The Spryte n OCT Imaging System uses high-resolution ...

Researchers implanted electrodes in the human nucleus accumbens to track brain activity during severe food preoccupation in ...

About 6.8 million Americans have an unruptured brain aneurysm,or roughly 1 in 50 people, according to Brain Aneurysm Foundation data. Many show no symptoms or warning signs until the aneurysm ruptures ...

Radiation-induced brain injury (RIBI) is a serious and often delayed complication of cranial radiotherapy, which remains a cornerstone in the treatment of brain tumors such as gliomas, metastases, and ...

The study evaluated the safety and efficacy of Nexalin’s 15 milliamp (mA) neurostimulation device in a patient diagnosed with both gambling disorder (GD) and alcohol use disorder (AUD). Following 20 ...

A research paper by scientists at the Capital Medical University evaluated sex differences in stroke recurrence among ...

A rare intracranial brain-recording study revealed that tirzepatide, a GLP-1 and GIP receptor agonist, temporarily silences craving-related neural activity in a key reward circuit of the brain.

In a historic leap for neurovascular medicine, XCath’s EVR robotic system has successfully treated three patients with ...

This article deconstructs the IIH guidelines, contrasting medical management (acetazolamide, topiramate) with the practical ...

XCath, a medical device company dedicated to pioneering neuro-endovascular surgical robotics, announced today the successful first-in-human use of its EVR robotic system to treat three patients with ...